Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2022 call → NOWe need to determine if management's forward account consists of narrating what its counterparties are themselves doing and scaling, such that the company's own volume is presented as a consequence of those parties' trajectories. The key is whether management speaks about specific customers/partners' own growth as the driver, with the company already embedded, and that growth early and large. Looking at the transcript: Management discusses various markets. For Japan, they mention strong demand for logs due to global logistics and Russian conflict, but they don't narrate a specific counterparty's expansion. For China, they mention constraints but not a specific counterparty's build-out. For carbon capture, they mention an agreement with Oxy Low Carbon Ventures, but that's a partnership for a project that will take years to come online; it's not about Oxy's own scaling that drives Weyerhaeuser's volume. For timberland acquisition, that's their own acquisition. The question is about whether management's forward account consists of reporting on the growth of specific customers/partners they already supply. The transcript does not show that. Management talks about market conditions, demand, pricing, but not about specific counterparties' own ramps. For example, they mention "our customers" but not specific named parties with their own trajectories. The only specific partner is Oxy, but that's a joint project, not a counterparty whose growth drives Weyerhaeuser's volume. Also, the project is not yet producing. Thus, the answer is NO. Answer: NO
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.